American Association for Cancer Research
Browse
00085472can092090-sup-sfig_3.pdf (121.08 kB)

Supplementary Figure 3 from ETS-1 Oncogenic Activity Mediated by Transforming Growth Factor α

Download (121.08 kB)
journal contribution
posted on 2023-03-30, 19:48 authored by Chet E. Holterman, Aleksandra Franovic, Josianne Payette, Stephen Lee
Supplementary Figure 3 from ETS-1 Oncogenic Activity Mediated by Transforming Growth Factor α

History

ARTICLE ABSTRACT

Inappropriate expression of Ets-1 is observed in a variety of human cancers, and its forced expression in cultured cells results in transformation, autonomous proliferation, and tumor formation. The basis by which Ets-1 confers autonomous growth, one of the primary hallmarks of cancer cells and a critical component of persistent proliferation, has yet to be fully explained. Using a variety of cancer cell lines, we show that inhibition of Ets-1 blocks tumor formation and cell proliferation in vivo and autonomous growth in culture. A screen of multiple diffusible growth factors revealed that inhibition of Ets-1 results in the specific downregulation of transforming growth factor α (TGFα), the proximal promoter region of which contains multiple ETS family DNA binding sites that can be directly bound and regulated by Ets-1. Notably, rescuing TGFα expression in Ets-1–silenced cells was sufficient to restore tumor cell proliferation in vivo and autonomous growth in culture. These results reveal a previously unrecognized mechanism by which Ets-1 oncogenic activity can be explained in human cancer through its ability to regulate the important cellular mitogen TGFα. Cancer Res; 70(2); 730–40

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC